ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

New Two-Step Matching Process Increases Success of Transplants

September 30, 2011

NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification

April 10, 1981

Declining Support Among Oncologists For Euthanasia.

October 13, 2000

FDA Offers Grants For Conferences

May 1, 1987

Physicians Accept Plans by City of Hope to Pay for Services Through New Foundation

June 3, 2011

FDA Concerned About Data-Dredging In Drug-Diagnostic Applications

January 30, 2009